Streetbeat News

Price Targets

GOOGL

Piper Sandler analyst Thomas Champion has maintained an Overweight rating on Alphabet (NASDAQ:GOOGL) and raised the price target from $147 to $150.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 5:49 pm

TXN

Truist Securities analyst William Stein has maintained a 'Hold' rating on Texas Instruments (NASDAQ:TXN) but lowered the price target from $165 to $150.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 5:46 pm

SPOT

Truist Securities analyst Matthew Thornton has maintained a 'Buy' rating on Spotify Technology (NYSE:SPOT) and raised the price target from $176 to $190.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 5:44 pm

PII

Truist Securities analyst Michael Swartz has maintained a 'Hold' rating on Polaris (NYSE:PII) and lowered the price target from $125 to $100.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 5:42 pm

HCA

Truist Securities analyst David Macdonald has maintained a 'Buy' rating on HCA Healthcare (NYSE:HCA), but lowered the price target from $340 to $300.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 5:40 pm

DLTR

Truist Securities analyst Scot Ciccarelli has maintained a 'Buy' rating on Dollar Tree (NASDAQ:DLTR) and raised the price target from $128 to $129.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 5:38 pm

CSGP

Truist Securities analyst Andrew Jeffrey maintains a 'Buy' rating on CoStar Gr (NASDAQ:CSGP) but has lowered the price target from $100 to $85.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 5:37 pm

AWI

Truist Securities analyst Keith Hughes maintains a 'Buy' rating on Armstrong World Industries (NYSE:AWI) and raises the price target from $90 to $95.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 5:35 pm

TXN

Mizuho analyst Vijay Rakesh maintains a Neutral rating on Texas Instruments (NASDAQ:TXN) and lowers the price target from $181 to $160.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 5:27 pm

HCA

Mizuho analyst Ann Hynes has maintained a 'Buy' rating on HCA Healthcare (NYSE:HCA) but lowered the price target from $325 to $275.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 5:26 pm